Chemotherapy for Colorectal Cancer
Open Access
- 21 April 1994
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (16), 1136-1142
- https://doi.org/10.1056/nejm199404213301608
Abstract
Carcinoma of the large bowel, which will afflict over 150,000 Americans this year, is second only to lung cancer as a cause of death from cancer1. Although most patients present with surgically resectable disease, almost half die of the cancer. Radiation therapy has a largely palliative role. In the past, chemotherapy resulted in only infrequent and usually transient shrinkage of the tumor, scarcely justifying the discomforts and costs of the treatment. In recent years, however, there have been some advances. In the discussion that follows, credence is given only to therapeutic claims validated by controlled trials with sufficiently long . . .Keywords
This publication has 63 references indexed in Scilit:
- NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancerJAMA, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trialBritish Journal of Surgery, 1989
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancerBritish Journal of Surgery, 1985
- Adjuvant Therapy of Colon Cancer — Results of a Prospectively Randomized TrialNew England Journal of Medicine, 1984
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983